Outlook on the Clinical Trials Matching Software Global Market to 2027 - Integration of Artificial Intelligence in Clinical Trial Matching Services Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trials Matching Software Market Research Report by Deployment (Cloud & Web Based and On-Premise), End-use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Clinical Trials Matching Software Market size was estimated at USD 172.12 million in 2021 and expected to reach USD 194.27 million in 2022, and is projected to grow at a CAGR 13.12% to reach USD 360.72 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trials Matching Software Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Trials Matching Software Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trials Matching Software Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trials Matching Software Market?

4. What is the competitive strategic window for opportunities in the Global Clinical Trials Matching Software Market?

5. What are the technology trends and regulatory frameworks in the Global Clinical Trials Matching Software Market?

6. What is the market share of the leading vendors in the Global Clinical Trials Matching Software Market?

7. What modes and strategic moves are considered suitable for entering the Global Clinical Trials Matching Software Market?

Market Dynamics

Drivers

• Rising need for clinical trials in healthcare domain
• Significant requirement for precision oncology
• Potential demand for virtual trials and automation in the healthcare sector

Restraints

• Concern associated with accuracy of clinical trial results

Opportunities

• Ongoing research and development activities in pharmaceuticals and biotechnology sector
• Integration of artificial intelligence in clinical trial matching services

Challenges

• Dearth of skilled and experienced professionals

Companies Mentioned

• Advarra
• Antidote Technologies, Inc.
• Aris Global
• BSI Business Systems Integration Ag
• Clario
• Clinical Trials Mobile Application
• Evidation Health, Inc.
• HealthMatch Pty Ltd
• Inspirata, Inc.
• International Business Machines Corporation
• IQVIA
• Microsoft Corporation
• Ofni Systems
• PatientsLikeMe LLC
• SSS International Clinical Research
• Teckro
• Tempus Labs
• Trialbee AB
• TrialSpark, Inc.
• Xperii Corporation

For more information about this report visit https://www.researchandmarkets.com/r/heod91

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900